
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1249 | 1017 | 1249 | 1262 | 2194 | 4394 |
Fund Return | 24.88% | 1.72% | 24.88% | 8.05% | 17.01% | 15.96% |
Place in category | 788 | 950 | 788 | 379 | 262 | 93 |
% in Category | 73 | 84 | 73 | 42 | 31 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 34.43B | 0.23 | 9.28 | 10.26 | ||
T. Rowe Price Capital AppreciationI | 28.94B | 0.26 | 9.42 | - | ||
T. Rowe Price Blue Chip Growth | 28.84B | -7.63 | 15.63 | 13.38 | ||
T. Rowe Price Blue Chip Growth I | 26.75B | -7.58 | 15.77 | - | ||
T. Rowe Price Instl Large Cap Growt | 20.27B | -6.60 | 15.83 | 14.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Growth Fund Amer A | 144.39B | -4.70 | 13.98 | 12.57 | ||
Fidelity Contrafund | 133.44B | -3.29 | 18.13 | 14.54 | ||
Vanguard Growth Index Adm | 80.2B | -7.50 | 15.47 | 14.47 | ||
JPMorgan Large Cap Growth R6 | 64.48B | -6.48 | 16.50 | 16.50 | ||
Fidelity Blue Chip Growth | 54.71B | -12.53 | 16.00 | 16.01 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 7.28 | 210.79 | +6.18% | |
Microsoft | US5949181045 | 6.98 | 449.26 | +2.40% | |
NVIDIA | US67066G1040 | 6.24 | 123.00 | +5.44% | |
Meta Platforms | US30303M1027 | 3.74 | 639.43 | +7.92% | |
Amazon.com | US0231351067 | 2.92 | 208.64 | +8.07% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Neutral |
Summary | Strong Buy | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review